Group One Trading’s Evogene EVGN Stock Holding History

Group One Trading’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13	Closed	-$93	–	6930
2024 Q1	$93	Sell	13 -100	-88%	-$834	﹤0.01%	6845
2023 Q4	$946	Hold	113	–	–	﹤0.01%	6998
2023 Q3	$660	Sell	113 -151	-57%	-$1.32K	﹤0.01%	7291
2023 Q2	$2.83K	Buy	264 +248	+1,550%	+$1.68K	﹤0.01%	6963
2023 Q1	$101	Sell	16 -327	-95%	-$2.43K	﹤0.01%	7034
2022 Q4	$2.4K	Sell	343 -2,722	-89%	-$19.2K	﹤0.01%	6599
2022 Q3	$25K	Buy	3,065 +841	+38%	+$8.11K	﹤0.01%	5920
2022 Q2	$17K	Sell	2,224 -2,096	-49%	-$20.5K	﹤0.01%	6402
2022 Q1	$56K	Buy	4,320 +2,014	+87%	+$27.2K	﹤0.01%	6003
2021 Q4	$38K	Buy	+2,306	New	+$52.3K	﹤0.01%	6530
2021 Q2	–	Sell	-8	Closed	-$313	–	8254
2021 Q1	$0	Buy	+8	New	+$495	﹤0.01%	7684

Other funds holding EVGN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JIC

Joel Isaacson & Co New York $3.02B AUM 21.81% 1-Year Est. Return

Group One Trading's EVGN Position: Q2 2024 in Review

Group One Trading sold out of Evogene (EVGN) in Q2 2024, closing a stake of 13 shares — an estimated $93 sold.

Group One Trading first reported a position in EVGN in Q1 2021 and held it in 11 quarters. The position peaked at $56K in Q1 2022. 28 funds tracked by Wall St. Rank hold EVGN as of Q2 2024.

Group One Trading reported no remaining Evogene position as of Q2 2024 after selling out during the quarter.
Group One Trading sold 13 Evogene shares in Q2 2024, an estimated $93.
Group One Trading first reported a position in Evogene in Q1 2021 and held it in 11 quarters.
Group One Trading's Evogene position peaked at $56K in Q1 2022.
28 funds tracked by Wall St. Rank held Evogene as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.